Firms

Human Capital

New York, New York · Stanford, California

Human Capital is a multi-stage venture firm that also helps founders assemble teams. The brand represents multiple separately existing entities. Current firm-wide check bounds, AUM and final fund closes remain unverified; HCM VI regulatory amount sold is distinct from a final close or target.

Founded: —
Type: Venture capital

Funds1

HCM VI, L.P.2025-01-212025-01-21—
Form D/A reports USD 419090909 sold including GP/affiliate commitments, offering and remaining amounts indefinite. Signed January 17/filed January 21 2025; formed 2023, first sale January 19 2024. Regulatory amount sold is not a target, final close or AUM; generic amount field left unknown.

Team

Baris Akis Human Capital, Co-Founder & President	$1M$100K – $10M	Stanford, California
Ishan Sinha Human Capital, Investor	$375K$250K – $500K	New York, New York
Matthew Colford Human Capital, Partner	$375K$250K – $500K	San Francisco Bay Area

Investments

$650M2025-06-02	Neuralink	GV, Founders Fund, DFJ Growth, ARK, Vy Capital, G42, Human Capital, Lightspeed Venture Partners, Qatar Investment Authority, Sequoia Capital, Thrive Capital, Valor Equity Partners, Sequoia, Lightspeed
$52M2025-12-11	Medra	Human Capital, Lux Capital, Neo, NFDG, Catalio Capital Management, Menlo Ventures, Seven Seven Six
$50M2025-11-12	Maybern	Battery Ventures, Primary Venture Partners, Human Capital, MetaProp, Grafton Street Partners, Camber Creek, Friends & Family Capital
$50M2025-06-10	AIM	Khosla Ventures, General Catalyst, Human Capital, Mantis Venture Capital, DCVC, Ironspring Ventures, Elad Gil, Sven Strohband
$130M2025-05-06	NewLimit	Founders Fund, Kleiner Perkins, Khosla Ventures, Dimension, Human Capital
$126M2024-05-02	Transcarent	General Catalyst, 7wireVentures, Human Capital, Geodesic Capital, Memorial Hermann Health System, Threshold Ventures, Kinnevik, Ally Bridge Group, Leaps by Bayer, Merck Global Health Innovation Fund, Alta Partners
$33M2023-05-24	Elementl	Georgian, 8VC, Human Capital, Sequoia Capital, Index Ventures, Amplify Partners, Hanover Technology Investment Management, Slow Ventures
$1.48B2022-12-02	Anduril	Valor Equity Partners, Lightspeed, Founders Fund, 8VC, Andreessen Horowitz, General Catalyst, Lux Capital, Thrive, DFJ Growth, Elad Gil, Lachy Groom, Marlinspike, Human Capital, WCM Investment Management, MVP Ventures, US Innovative Technology
$39M2022-09-14	Kojo	Battery Ventures, Schneider Electric, RXR, Bienville Capital, 8VC, Suffolk Construction, Human Capital, AME Cloud Ventures, BoxGroup
$25M2022-02-01	Jasper Health	General Catalyst, Human Capital, W Health Ventures, Redesign Health, 7wireVentures, Candace Richardson
$100M2021-09-14	Splitgate	Lightspeed Venture Partners, Insight Partners, Anthos Capital, Galaxy Interactive, VGames, Human Capital, Lakestar, Draper Dragon, Draper University
$25M2021-06-28	Local Kitchens	General Catalyst, Human Capital, Pear VC, Fifth Wall, Penny Jar Capital
$23M2021-05-18	Hearth	Human Capital, Barry Sternlicht, Jay N. Levine, 8VC, SuRo Capital, The Chainsmokers
$120M2020-08-14	Wildlife	Vulcan Capital, Human Capital
$200M2020-07-01	Anduril	Founders Fund, Trae Stephens, Andreessen Horowitz, General Catalyst, 8VC, Human Capital, Valor Equity Partners, Lux Capital, Elad Gil
$41M2018-06-11	Anduril	Founders Fund, 8VC, Human Capital, General Catalyst, SV Angel
$—Unknown date	Zelos	Human Capital
$—Unknown date	Yendo	Human Capital
$—Unknown date	x.ai	Human Capital
$—Unknown date	Wraithwatch	Human Capital
$—Unknown date	Wildlife	Human Capital
$—Unknown date	Vise	Human Capital
$—Unknown date	Transcarent	Human Capital
$—Unknown date	Trackonomy	Human Capital
$—Unknown date	The Boring Company	Human Capital
$—Unknown date	Studio	Human Capital
$—Unknown date	Splitgate	Human Capital
$—Unknown date	Speechify	Human Capital
$—Unknown date	SpaceX	Human Capital
$—Unknown date	Snowflake	Human Capital
$—Unknown date	Scale	Human Capital
$—Unknown date	Sanas	Human Capital
$—Unknown date	Rune	Human Capital
$—Unknown date	Qualia	Human Capital
$—Unknown date	Posh	Human Capital
$—Unknown date	Onebrief	Human Capital
$—Unknown date	Observe	Human Capital
$—Unknown date	Nuvo	Human Capital
$—Unknown date	Nova Credit	Human Capital
$—Unknown date	Nominal	Human Capital
$—Unknown date	Monaco	Human Capital
$—Unknown date	ModRetro	Human Capital
$—Unknown date	Medra	Human Capital
$—Unknown date	Maybern	Human Capital
$—Unknown date	Local Kitchens	Human Capital
$—Unknown date	Livongo	Human Capital
$—Unknown date	Lean Technologies	Human Capital
$—Unknown date	Lacework	Human Capital
$—Unknown date	Kojo	Human Capital
$—Unknown date	Kalshi	Human Capital
$—Unknown date	Jasper Health	Human Capital
$—Unknown date	Homeward	Human Capital
$—Unknown date	Hearth	Human Capital
$—Unknown date	Flock	Human Capital
$—Unknown date	Fellow	Human Capital
$—Unknown date	Erebor	Human Capital
$—Unknown date	Elementl	Human Capital
$—Unknown date	Dandy	Human Capital
$—Unknown date	Commure	Human Capital
$—Unknown date	Clumio	Human Capital
$—Unknown date	Cloaked	Human Capital
$—Unknown date	Brex	Human Capital
$—Unknown date	Bolt	Human Capital
$—Unknown date	Biograph	Human Capital
$—Unknown date	Beacon	Human Capital
$—Unknown date	Athelas	Human Capital
$—Unknown date	Applied Intuition	Human Capital
$—Unknown date	AIM	Human Capital
$—Unknown date	Able	Human Capital

team@apexlogos.ai11 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and stages | Item | Amount/status/date | Evidence and interpretation | | --- | --- | --- | | HCM VI, L.P. | **USD 419,090,909 sold**, Form D/A filed 2025-01-21; signed 2025-01-17. Entity formed in 2023; first sale 2024-01-19. | [SEC filing](https://www.sec.gov/Archives/edgar/data/1997270/000199727025000001/xslFormDX01/primary_doc.xml) directly read. Offering size and remaining amount are indefinite; 30 investors. Amount includes GP and affiliate commitments. Armaan Ali is named and signs as managing member of issuer's GP. This is an offering amount sold, **not a verified final close, target or firm AUM**. | | Unverified historical directory estimate | USD 287 million; directory labels last fund January 2021. | [Shizune](https://shizune.co/investors/profile/human-capital-da7c), undated/current listing accessed 2026-10-06. No named fund or underlying announcement established. Its description also repeats $1.3 billion total committed capital. Do not promote either figure to verified current fund size. | | QIA relationship | Commitment to Human Capital not disclosed in announcement, 2025-02-20. | [QIA announcement](https://www.qia.qa/en/Newsroom/Pages/Human-Capital-joins-QIA%E2%80%99s-Fund-of-Funds-program-and-announces-office-opening-in-Doha.aspx). QIA's more-than-$1 billion Fund of Funds program size is **QIA's overall program**, not Human Capital's fund. | HCM VI is the latest dated primary fund-raising disclosure established in this pass, not a claim that it is the firm's newest fund. Searches for later Human Capital funds and HCM VII did not establish a newer primary final close. Third-party gross asset estimates for HCM VI (about $460 million) and the manager (over $2.7 billion) use different measures and remain unverified against the underlying ADV here. A directory claiming the SEC amount is combined across related vehicles conflicts with the direct filing's narrower wording, which says it includes GP and affiliate commitments; preserve the primary wording. **Current stage mandate:** multi-stage, explicitly supported by the [official About page](https://human.capital/about), undated/accessed 2026-10-06, and the [QIA announcement](https://www.qia.qa/en/Newsroom/Pages/Human-Capital-joins-QIA%E2%80%99s-Fund-of-Funds-program-and-announces-office-opening-in-Doha.aspx), 2025-02-20. Historical examples below establish Series A, B and E transactions; they do not define current entry-stage restrictions. No verified firm-wide check-size policy found. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | HCM VI, L.P. | Undisclosed / unverified | 2025-01-21 |
team@apexlogos.ai12 hours ago
Match research 2026-10-06 / HumanCapital / sha256:c8fd06255f4e514251ba4e3501d8b3c2fea823457cd7d7049a5c4da7c2d8f84a / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. ## Named previous neurotech investment **Neuralink — verified direct neurotech and deep-tech investment.** Neuralink develops implanted brain interfaces for people with paralysis to control devices using neural activity. Its **2025-06-02** official announcement reports a **closed USD 650 million Series E** and explicitly includes **Human Capital** among institutional investors. This is firm attribution, not an inference from a partner's prior employment. Human Capital's own amount and lead status are not disclosed. [Official financing announcement](https://neuralink.com/updates/neuralink-raises-650m-series-e/) initially returned an empty body when opened; a targeted official-domain search exposed its dated announcement and investor list. [Reuters report, 2025-06-02, mirrored by Investing.com](https://www.investing.com/news/economy/musks-neuralink-raises-650-million-in-latest-funding-round-4076532) corroborates the funding and named investor. The [official firm portfolio](https://human.capital/portfolio), accessed 2026-10-06, also lists Neuralink. Reuters notes an earlier report of $600 million; use the announced $650 million Series E figure and distinguish that from earlier reporting. No second directly verified neural/brain technology investment was established. Medra's founders having worked at Neuralink would not make Medra itself a neurotech company. NewLimit's longevity research, Jasper Health's cancer care and Livongo's chronic-care platform should not be relabeled neurotech without separate evidence. ## Attribution caveats, gaps and later Adex review - The [firm's legal disclosures](https://human.capital/legal), undated/accessed 2026-10-06, explain that Human Capital denotes multiple separately existing entities. Preserve brand-level attribution unless a specific financing vehicle is named. HCM VI's connection is supported by the overlapping Armaan Ali identity and the issuer/manager directory evidence; do not imply every portfolio holding came from HCM VI. - QIA describes a Doha office to be opened by affiliate **HCF LLC**, not necessarily a direct investment-fund office already operating. No opening completion or QIA commitment amount verified. - Later Adex review can attach the dated Neuralink financing evidence to its currently undated portfolio relationship, retain Medra's verified lead status, and add/reconcile NewLimit's dated Series B evidence. Deduplicate company-level portfolio entries from dated rounds without discarding provenance. - Review stale role/location claims against the official team and regulatory address. Signal's New York/Stanford display is not a complete verified office inventory. - Fund target, final close, latest full fund vintage, verified current total AUM, exact check policy, investment ownership percentages, and firm-specific check amounts remain missing. Regulatory amount sold must be stored with its date and measurement, not as a generic current fund-size assertion. - The 69 snapshot entries were inspected as leads; this report verifies selected relevant deep-tech/neurotech holdings, not every historical transaction. Portfolio listing proves a relationship, not the timing or route of investment; recruiting relationships should also not be confused with investments. All web sources above were accessed **2026-10-06**. Publication dates are stated beside dated claims; undated pages use the access date. Source limitations are explicit so the file can support later review independently of the chat and raw snapshot.
team@apexlogos.ai12 hours ago
Match research 2026-10-06 / HumanCapital / sha256:c8fd06255f4e514251ba4e3501d8b3c2fea823457cd7d7049a5c4da7c2d8f84a / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Human Capital - **Exact Adex ID:** `HumanCapital` - **Adex URL:** https://adex.page/firms/HumanCapital - **Official website:** https://human.capital/ - **Research date:** 2026-10-06 - **Status:** Complete research pass; outstanding uncertainties are identified below. Research only; no Adex/database changes. Human Capital describes itself as a multi-stage venture firm that also helps founders assemble teams. Verified investments span autonomous defense systems, laboratory robotics, epigenetic medicine and implanted brain interfaces. Neuralink provides a clear, directly attributable neurotech precedent. The strongest fund-size evidence found is an HCM VI regulatory offering disclosure, rather than a public final-close announcement. [Official strategy, undated](https://human.capital/about); [Neuralink announcement, 2025-06-02](https://neuralink.com/updates/neuralink-raises-650m-series-e/). ## Starting evidence: Adex and NFX Signal The saved exact-ID snapshot, `data/research/_sources/HumanCapital.adex.json`, was retrieved 2026-10-06 at 19:29:55 UTC. It contains the Match label, BCI sector, null check-size fields, and 69 investment entries, including duplicate company-level portfolio and financing records. It names Baris Akis as Managing Partner, Ishan Sinha as Investor and Matthew Colford as Partner. Its imported neurotechnology evidence identifies Neuralink's June 2025 Series E, although the investment list itself has an undated portfolio entry for Neuralink. It also supplies official Medra and Anduril financing leads and many undated portfolio entries. These are starting records, not independent corroboration. [NFX firm page](https://signal.nfx.com/firms/human-capital) was directly opened; its accessible text names Human Capital and lists New York and Stanford locations. [Baris Akis profile](https://signal.nfx.com/investors/baris-akis) was directly read and displays Managing Partner, a $100,000–$10 million investment range and $1 million sweet spot, with Seed/Series A/Series B sector rankings. [Ishan Sinha profile](https://signal.nfx.com/investors/ishan-sinha) displays Investor, $250,000–$500,000 range and $375,000 sweet spot, with Seed and Series A rankings. Investment details are sign-in restricted; displayed counts can differ between profile sections. These are individual profile claims, not verified firm-wide limits or current stage mandates. All Signal pages are undated, accessed 2026-10-06. The [current official team](https://human.capital/about), accessed 2026-10-06, instead calls Baris Akis Co-Founder & President and Armaan Ali Co-Founder & CEO. Ishan Sinha and Matthew Colford were not found on that published team list. This warrants role review rather than assuming Signal or snapshot titles remain current. ## Fund size and stages | Item | Amount/status/date | Evidence and interpretation | | --- | --- | --- | | HCM VI, L.P. | **USD 419,090,909 sold**, Form D/A filed 2025-01-21; signed 2025-01-17. Entity formed in 2023; first sale 2024-01-19. | [SEC filing](https://www.sec.gov/Archives/edgar/data/1997270/000199727025000001/xslFormDX01/primary_doc.xml) directly read. Offering size and remaining amount are indefinite; 30 investors. Amount includes GP and affiliate commitments. Armaan Ali is named and signs as managing member of issuer's GP. This is an offering amount sold, **not a verified final close, target or firm AUM**. | | Unverified historical directory estimate | USD 287 million; directory labels last fund January 2021. | [Shizune](https://shizune.co/investors/profile/human-capital-da7c), undated/current listing accessed 2026-10-06. No named fund or underlying announcement established. Its description also repeats $1.3 billion total committed capital. Do not promote either figure to verified current fund size. | | QIA relationship | Commitment to Human Capital not disclosed in announcement, 2025-02-20. | [QIA announcement](https://www.qia.qa/en/Newsroom/Pages/Human-Capital-joins-QIA%E2%80%99s-Fund-of-Funds-program-and-announces-office-opening-in-Doha.aspx). QIA's more-than-$1 billion Fund of Funds program size is **QIA's overall program**, not Human Capital's fund. | HCM VI is the latest dated primary fund-raising disclosure established in this pass, not a claim that it is the firm's newest fund. Searches for later Human Capital funds and HCM VII did not establish a newer primary final close. Third-party gross asset estimates for HCM VI (about $460 million) and the manager (over $2.7 billion) use different measures and remain unverified against the underlying ADV here. A directory claiming the SEC amount is combined across related vehicles conflicts with the direct filing's narrower wording, which says it includes GP and affiliate commitments; preserve the primary wording. **Current stage mandate:** multi-stage, explicitly supported by the [official About page](https://human.capital/about), undated/accessed 2026-10-06, and the [QIA announcement](https://www.qia.qa/en/Newsroom/Pages/Human-Capital-joins-QIA%E2%80%99s-Fund-of-Funds-program-and-announces-office-opening-in-Doha.aspx), 2025-02-20. Historical examples below establish Series A, B and E transactions; they do not define current entry-stage restrictions. No verified firm-wide check-size policy found. ## Named previous deep-tech investments All amounts below are total company rounds, not Human Capital's own checks. Technology classification is this researcher's assessment based on the cited company descriptions. | Company | Technology rationale | Firm attribution and financing evidence | | --- | --- | --- | | **Medra** | Physical AI integrated with robotics to perform laboratory experiments and interpret results; substantive laboratory automation rather than ordinary SaaS. | Human Capital **led USD 52 million Series A**, announced **2025-12-11**. [Official announcement](https://www.medra.ai/series-a) directly opened but extracted incompletely; [company-issued Business Wire release mirrored by Yahoo](https://finance.yahoo.com/news/medra-raises-52-million-series-130000298.html) supplies the full attribution. [Bloomberg reporting](https://news.bloomberglaw.com/daily-labor-report/medra-raises-52-million-to-speed-drug-discovery-with-ai-robots), 2025-12-11, independently calls Human Capital the lead and an existing investor. Earlier investor status is supported, but an earlier check/round amount was not established. | | **Anduril** | Autonomous defense hardware, drones and related AI/autonomy systems. | Human Capital participated in **USD 1.48 billion Series E**, **2022-12-02**, led by Valor Equity Partners. [Official URL](https://www.anduril.com/news/anduril-raises-usd1-48-billion-in-series-e-funding) opened with essentially no extractable body; [Axios](https://www.axios.com/2022/12/02/anduril-capital-raise-billion-defense-technology), dated 2022-12-02, verifies the named participant. Snapshot's 2018/2020 rounds rely on directories and were not independently verified here. | | **AIM Intelligent Machines** | Embodied AI that makes construction/mining earthmoving machinery operate autonomously. | [Official release](https://www.aim.vision/blog/press-release), undated/accessed 2026-10-06, announces **USD 50 million funding** and names Human Capital among investors. Snapshot dates it **2025-06-10**, consistent with contemporaneous reporting leads; exact announcement date and stage are not displayed in the extracted official release. This establishes firm backing, but the investor roster should not be overread as evidence of a particular individual check. | | **NewLimit** | Experimental epigenetic reprogramming medicines aimed at extending healthspan; biological R&D. | [Official company blog](https://blog.newlimit.com/p/newlimit-raises-130-million-series), **2025-05-06**, announces **USD 130 million Series B** led by Kleiner Perkins and explicitly names Human Capital as a new investor. Longevity biotech; no direct neural-interface or brain technology demonstrated by this source. | | **Applied Intuition; SpaceX; The Boring Company** | Autonomy infrastructure, spacecraft/launch engineering and tunneling engineering respectively; reasonable additional deep-tech leads. | The [official portfolio](https://human.capital/portfolio), undated/accessed 2026-10-06, directly names all three. Supports firm-level portfolio relationship only: specific vehicles, transaction dates, primary/secondary status, amounts and rounds were not established in this pass. Do not fabricate financing records from the listing. | The official portfolio also lists xAI, but general AI alone does not establish neurotechnology. Ordinary financial/workflow SaaS names in the snapshot (for example Maybern or Kojo) are not counted as deep tech merely because they use software.
team@apexlogos.ai27 days ago
MATCH

Funds1

Team

Co-investing

Investments